Thyrocare Technologies (THYROCARE.NS) Earnings Analysis
Thyrocare Technologies (THYROCARE.NS) next reports earnings on 2026-07-23, consensus EPS 6.77 INR. Last quarter (2026-05-07) it missed with EPS 3.18 INR vs 5.4 INR est (-41.1%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E 25.65.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does THYROCARE.NS next report earnings?
| Next earnings date | 2026-07-23 |
|---|---|
| Consensus EPS estimate | 6.77 INR |
| Revenue estimate | 2.28B |
THYROCARE.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 3.18 INR | 5.4 INR | -41.1% | Miss |
| 2026-01-28 | 4.3 INR | 4.5 INR | -4.4% | Miss |
| 2025-10-21 | 6.05 INR | n/a | n/a | n/a |
| 2025-07-23 | 2.43 INR | 1.7 INR | +42.9% | Beat |
| 2025-01-23 | 1.2 INR | 1.4 INR | -14.3% | Miss |
| 2024-07-23 | 1.57 INR | 1.5 INR | +4.7% | Beat |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
THYROCARE.NS valuation and analyst view
| Trailing P/E | 25.65 |
|---|---|
| Trailing EPS | 10.351 INR |
| Price / book | 14.64 |
| Dividend yield | 1.72% |
| Market cap | 29.60B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Thyrocare Technologies (THYROCARE.NS)'s next earnings date?
Thyrocare Technologies is next scheduled to report on 2026-07-23, with a consensus EPS estimate of 6.77 INR and revenue estimate of 2.28B.
Did THYROCARE.NS beat earnings last quarter?
In its 2026-05-07 report, THYROCARE.NS posted EPS of 3.18 INR versus a 5.4 INR estimate — a miss of 41.1%.
What is THYROCARE.NS's earnings track record?
Over the last 5 reported quarters with consensus data, THYROCARE.NS beat estimates 2 times (40%).
What is THYROCARE.NS's current P/E ratio and EPS?
THYROCARE.NS trades at a trailing P/E of 25.65 on trailing EPS of 10.351043101314428 INR.
What do analysts rate THYROCARE.NS?
THYROCARE.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.